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In response to various perturbations of DNA replication, the DNA replication checkpoint is 
activated in eukaryotes to stimulate a cascade of cellular responses that are crucial for 
maintaining genome stability and cell survival. Defects in the checkpoint pathway result in 
mutations and genome instability, which is a hallmark for cancers. This study used a genetic 
approach to identify a mutation in the MMS (methyl methanesulfonate) and UV-sensitive 
protein Mus81, a DNA repair enzyme that resolves aberrant DNA structures through the 
homologous recombination pathway. We show that a single missense mutation, identified in 
fission yeast mus81-1, causes moderate reduction in the phosphorylation levels of the major 
DNA replication checkpoint proteins Mrc1(Claspin) and Cds1(Chk2) in fission yeast. We also 
show that the mutation directly affects the DNA repair and the DNA damage checkpoint 
mediated by Chk1 that causes dramatic cell lethality in mus81-1 mutant upon treatment with 
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CHECKPOINT SIGNALING PATHWAYS 
The cell cycle is a highly regulated process in the cell during which DNA is duplicated 
followed by division of the cell and organelles. The most important stage of the cell cycle, S 
phase where DNA duplication takes place must be completed with high fidelity to ensure 
genome stability (Burhans, Carr & Wahl, 2006). Inefficient completion of this phase results 
in under replication of the genome and unhealthy cells after mitotic division. DNA replication 
is however constantly under attack by factors of both endogenous and exogenous sources 
including depletion of nucleotides, inhibition of polymerase activity or damage to the DNA 
template resulting in fork stalling (McGowan & Russell, 2014; Tsang & Carr, 2008). Stalled 
forks, if unresolved properly, can lead to chromosomal aberrations or even cell death (Ciccia 
& Elledge, 2010). Eukaryotes have evolved regulated mechanisms including the cell cycle 
checkpoint that functions as a surveillance mechanism that monitors cell cycle progression to 
ensure that each phase of the cell cycle is completed with accuracy and precision before 
moving to the next phase of the cell cycle (Boddy, 1999; Sasi & Weinreich, 2016). The two 
most studied cell cycle checkpoints in the fission yeast Schizosaccharomyces pombe are the 
DNA replication checkpoint (DRC) and the DNA damage checkpoint (DDC). The DRC 
monitors the progress of replication forks during normal S phase or under replication stress 
(Rhind & Russell, 2010; Yue et al., 2011; Boddy, 1999; Ait Saada et al., 2017). In response 
to DNA damage at the G2 phase, the DDC is activated to halt mitosis so that the cells have 
enough time to properly repair the DNA damage. It is important to note that whiles the DRC 
only slows the S phase, the DDC may completely arrest cell cycle upon DNA damage such 
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as strand breaks (Boe et al., 2012 & Boddy, 1999). 
The DNA checkpoint pathways consist of three main functional units; sensors, mediators and 
effectors. Sensors detect damaged DNA or stalled replication forks, mediators serve as signal 
transducers that amplifies the checkpoint signal, and the effectors elicit the protective cellular 
responses such as induction of apoptosis, DNA repair, halting cell cycle progression or 





Figure 1. The checkpoint signaling pathways in the fission yeast S. pombe. In an event of 
fork perturbation at the S phase, Rad3 (ATR in mammalian cells) the major sensor kinase 
complexes with its subunit Rad26 (ATRIP in mammalian cells) is activated. The 9-1-1 
complex consisting of Rad1, Rad 9 and Hus1 (Table 1) is also loaded at the site of the stalled 
fork through a clamp holder, Rad 17 which is related to the Rfc1 in loading the proliferating 
cell nuclear antigen (PCNA) (Bermudez et al., 2010; Ellison et al., 2003). Rad3 begins the 
DRC signaling after successful recruitment of the above mentioned sensors to the stalled 
replication site. Rad3 first activates the mediator Mrc1 (Claspin in human cells) which induces 
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the downstream phosphorylation of Cds1 (CHK2 in human cells), the effector kinase for the 
DRC (Tanaka & Russell, 2001; Xu, Davenport & Kelly, 2006). If the DNA damage occurs 
outside S phase, Rad3 activates the DDC by activating the mediator Crb2 (53BP1 in human 
cells) which facilitates the phosphorylation of Chk1, the effector kinase for the DDC 
(Nakamura et al., 2004; Saka et al., 1997).  
Understanding the mechanisms of checkpoint defects is critical not only in cell cycle 
regulation but also for studying cell proliferation and genetic diseases, most notably cancer 
















Table 1: Conserved checkpoint proteins in eukaryotes.   
Function S. pombe Human S. cerevisiae 
Sensors Rad3 ATR Mec1 
 
Tel1 ATM Tel1 
 
Rad26  (Rad3 subunit) ATRIP Ddc2 
 
Rad17  (“9-1-1” loader) hRAD17 Rad24 
 
Rad9 hRAD9 Ddc2 
 
Rad1 hRAD1 Rad17 
 
Hus1 hHUS1 Mec3 
Mediators Mrc1 Claspin Mrc1 
 
Crb2 53BP1 Rad9 
Effectors Cds1 hCHK2 Rad53 
 
Chk1 hCHK1 Chk1 













Methyl methane sulfonate (MMS), and UV-sensitive protein Mus81  
In an attempt to restore stalled replication fork, a nearby origin can be fired to continue the 
stalled replication. An alternative mechanism used by the cell to restore stalled fork is through 
the homologous recombination (HR) pathway mediated by Mus81 (Brambati et al., 2018 
; Yekezare, Gomez-Gonzalez & Diffley, 2013). Mus81 resolves the four-way DNA junction 
formed during HR, by nicking the Holliday junctions and recombining the DNA duplexes 
before chromosome segregation (Wyatt et al., 2014) (Figure 2). Aberrant chromosome 
structures that result from perturbed forks are thus resolved through Mus81 complex.  Mus81 
belongs to a family of structure-specific endonucleases (SSEs) that catalyze endonucleolytic 
cleavage at Holliday junctions, which is explained as a single-stranded crossover between two 
homologous DNA duplexes (Chen et al., 2001; Smith et al., 2003) (Figure 2).  Defects in this 
pathway cause instability of the genome and cancers (Ait Saada, Lambert S-Silva & Carr, 
2018 ; Mayle et al., 2015). 
In human cells, Mus81 not only functions to resolve recombination intermediates (Chen et 
al., 2001; Wyatt et al., 2013), it also functions in telomere maintenance and replication fork 
restart (Hanada et al., 2007). A recent study however shows that the enzymatic activity of the 
Mus81 complex inhibits fork restart in S phase because the endonuclease activity is decreased 
in S phase and only increases in G2/M (Mayle et al., 2015). In contrast, another study proposes 
that Mus81 is actively involved in S phase where it recruits Cds1 to aberrant DNA structures 
(Boddy et al., 2000).  
Although the role of Mus81 in chemotherapy is largely unknown, knockdown of Mus81 has 
been reported to improve chemosensitivity in colon cancer and hepatocellular carcinoma 
cells through S phase arrest and apoptosis via the Chk1 pathway (Wu et al., 2016; Wu et al., 
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2017). Inhibition of Mus81 has also been reported to sensitize ovarian cancer cells to 
chemotherapy by promoting apoptosis (Zhong et al., 2019). Downregulation of Mus81 may 
thus be used as a prognostic biomarker for early cancer detection and for cancer treatment 
(Wu et al., 2011). 
Genetic and physical interactions of Mus81 
Mus81 binds to Eme1 in S. pombe to form Mus81-Eme1 complex (Figure 2) (Boddy et al., 
2001). It physically interacts with Cds1, the effector kinase for the DRC (Boddy et al., 2000; 
Kai et al., 2005) and genetically interacts with Chk1 and Crb2 in the DDC pathway (Boddy 
et al., 2000; Kanoh et al., 2003). In S. cerevisiae, Mus81 binds to the protein named Mms4 to 
form the Mus81-Mms4 endonuclease (de los Santos et al., 2003). In humans, it binds two 
proteins namely; Eme1 and Eme2 to form Mus81-Eme1 and Mus81-Eme2 complexes with 
both exhibiting similar biochemical properties (Pepe & West, 2014).  
 
The agents used in this study that activate the DNA Replication Checkpoint  
The agents that disrupt DNA replication were used in this study to activate the DNA 
replication checkpoint and help understand if the mutant used in this study has a defective 
checkpoint gene. These agents include hydroxyurea (HU) that depletes deoxyribonucleotide 
triphosphates (dNTPs), methyl methane sulfonate (MMS), an DNA alkylating agent that alters 
bases in the template, ultraviolet (UV) light that forms abnormal covalent bond between 
adjacent pyrimidine bases, camptothecin (CPT) that locks topoisomerase I covalently onto 
the DNA, and bleomycin (BLM) that induces single and double stranded breaks (Zeman & 













Figure 2: Role of Mus81-Eme1 complex in cell cycle progression. 
Mus81-Eme1 complex resolves the four-way DNA junction formed during HR, by nicking 
the Holliday junctions (pointed arrows) and recombining the DNA duplex before 
chromosome segregation.  




Figure 3: Crystal structure of human Mus81 complex.                                                                                     
A. Mus81 complex bound to a 5’ flap DNA. The nuclease and nuclease-like domains are on 
top of the EHhH2 and MHhH2 domains, respectively. Substrate duplex DNA is shown with 
green and orange backbone. The 5’ end binding pocket is shown with blue dotted circle. The 
wedge is highlighted as black dotted circle                                                                                   
B. Mus81 complex bound to a 3′ flap DNA. Cleavage site is marked with an arrow and size 












Study model: the fission yeast Schizosaccharomyces pombe 
Fission yeast is an established model for studying the cellular mechanisms that are conserved 
in humans. Unlike human cells, fission yeast has a much shorter cell cycle time of 2-3 hours. 
It can be easily manipulated that allows tracking of DNA damage and replication stalling in 
S. pombe. It also has highly conserved checkpoint proteins (Table 1) allowing for 
identification and characterization of mutated genes to help understand genetic diseases 
conditions in humans. Lastly DNA damage and replication stalling can easily be studied by 
microscopy with this organism.  This organism therefore provides powerful genetic, genomic, 
molecular, and biochemical tools for checkpoint and cancer research.  
HYPOTHESIS  
The mutation(s) in the newly screened SN106 mutant may have a checkpoint defect which 
results in genome instability and cell death under stress. 
MAIN OBJECTIVE 
1. Characterize the newly screened SN106 mutant.  
SPECIFIC OBJECTIVES 
1. Confirm the drug sensitivity of the SN106 mutant. 
2. Identify the mutation and mutated gene. 
3. Examine the potential checkpoint defects. 






MATERIALS AND METHODS 
Yeast Strains, Plasmids and Chemicals 
Standard methods and genetic techniques were used for the S. pombe cell culture and the 
genetic screening. The S. pombe strains were usually cultured at 30°C in YE6S (0.5% yeast 
extract, 3% dextrose and the 6 essential supplements, adenine, uracil, histidine, lysine, 
leucine, and arginine) or in EMM medium lacking the appropriate supplements following 
standard methods. Malt extract (ME) medium with 4 supplements was used for mating 
purposes. MMS was used directly from the 99% stock solution (Sigma). HU (Sigma) was 
prepared as a 1.0 M stock solution in distilled water.  Phloxin B dye was used as an indicator 
of cell lethality. 
The collection of checkpoint mutants was derived from the wild type S. pombe YJ374 strain. 
The SN106 mutant was kindly provided by Dr. Saman Khan. The yeast strains, plasmids, and 
PCR primers used in this study are listed in Table 2, 3, and 4, respectively.  
Drug Sensitivity Test 
Drug sensitivity test for the mutants was performed by standard spot assay. 2 x 107 cells/ml 
of logarithmically growing S. pombe were diluted in 3-fold or 6-fold steps and spotted in 3 µl 
onto YE6S plates containing HU, MMS, BLM or CPT at the indicated concentrations in 
figures 4, 5 and 7. The cells spotted on YE6S plates were also treated with UV (Stratalinker 
2400). The plates were incubated at 30°C for 3 days and then photographed. Wild type cell 
was used as negative control while chk1Δ and rad3Δ, cds1Δ, and rhp51Δ cells were used as 





Immunoprecipitation (IP)   
Logarithmically growing cells were harvested and saved at -20˚C in a screw cap tube. The 
frozen cell pellets were lysed by mini-bead beater in the buffer containing 25 mM 
HEPES/NaOH (pH7.5), 50 mM NaF, 1 mM Na3VO4, 10 mM NaP2O7, 40 mM ß-
glycerophophate, 0.1% Tween 20, 0.5% NP-40, and protease inhibitors. The cell extract was 
incubated with anti-HA antibody beads by rotating in 2 ml tubes at 4˚C for 2 hrs. The beads 
were prewashed with TBS-T at 4˚C overnight. The samples were separated by SDS-PAGE 
followed by Western blotting. The blotting signal was detected by electrochemiluminescence 
using ChemiDoc XRS Imaging system (BioRad). Intensities of the bands were quantified and 
analyzed by ImageLab (BioRad). 
 
Western blotting analyses of phosphorylated Mrc1, Cds1 and Chk1  
For examination of Mrc1 phosphorylation, logarithmically growing cells were fixed in 15% 
trichloroacetic acid (TCA) on ice for ≥ 3h and then lysed by mini-bead beater. The lysates 
from 2 - 4 x 106 cells were separated by SDS-PAGE and detected in the whole cell lysates by 
Western blotting using phospho-specific antibody that detects phosphorylated Thr645 in Mrc1. 
The same blot was striped and then blotted with anti-Mrc1 antibodies to detect Mrc1 protein. 
Ponceau S staining was used as the loading control. For the examination of phosphorylated 
Cds1 and Chk1, the two proteins were tagged with myc or HA epitope at their genomic loci. 







0.5 OD logarithmically growing cells were collected, fixed in 1ml of ice-cold 70% ice-cold 
ethanol and store for 2 h. 0.3 ml of the fixed cells was then transferred in a new tube, pulse 
spin to discard the supernatant. 0.5 ml 50 mM Na-Citrate with 0.1mg/ml RNase A was added 
and incubated for 2 h. Before the analysis, 0.5 ml 50mM Na-Citrate with 4µg/ml PI was added. 
The samples were immediately analyzed by Accuri C6 flow cytometer. Data was analyzed 
using ‘FCS Express 4’ software. 
 
Microscopy 
 The cells were fixed directly onto uncoated glass slides by heating briefly at 98˚C for 2 
mins. Blankophor and Hoechst working solutions were prepared. 2 µl each these prepared 
solutions were spread on the dried plates. The stained cells were examined using an 
Olympus EX41 fluorescent microscope. Images were captured with an IQCAM camera 
(Fast1394) using Qcapture Pro 6.0 software. Images were also extracted into Photoshop 





Table 2: List of S. pombe strains used in the study 
Strain  Genotype  Source 
YJ374  h+ cds1-6his2HA(int) leu1-32 ura4-D18 ade6-M216  Xu Lab 
NW222  chk1-3HA leu1-32 ura4-D18 ade6-M210 Nancy Walworth Lab 
Y167  ∆rhp51::ura4+ leu1-32 ura4-D18 ade6-M210 Akira Yasui lab 
YJ60  cds1-6his2HA(int) leu1-32 ura4-D18 ade6-M210 Xu Lab 
NR1826  h- ∆rad3::ura4+ leu1-32 ura4-D18 ade6-M210  P. Russell Lab 
TK7  h- leu1-32 ura4-D18 ade6-M210 XuLab 
TK48  h+ leu1-32 ade6-M210 XuLab 
 
Table 3: List of Plasmids used in the study 
Name  Description  Source 
pYJ1339  pIRT-2U+prom+Mus81(SmaI-SphI)ura4+  Xu Lab 
pEme1  pWZ118[2U+prom+Eme1+term(SacI-BamHI)]  Xu Lab 
Mus81(slx3)  pYJ1339[2U+prom+Mus81(SmaI-SphI)]  Xu Lab 
pYJ162  pIRT-2L+prom Mrc[LEU2] Xu Lab 
pYJ283  pIRT-2L+prom Cds1[LEU2] Xu Lab 
 
 
Table 4: List of PCR and sequencing primers used in the study 
Name  Sequence (5’ -> 3’)  Note 
SpMus81(P)SmaI-f  aatgCcCgggtgttacagcgcac  Gene Cloning 
SpMus81(T)SphI-b  cagtGCatgcaaaatgcaaaatg  Gene Cloning 
Mus81(406-427)f  AGCACGCACAATGAACAGAATG  Sequencing 
Mus81(551-528)b  GAATATGCACCAGAACGATAGCTC  Sequencing 
Mus81(912-932)f  AAGTTCTTCAGACCACGGAGG Sequencing 





Confirming the drug sensitivity of the fission yeast mutant SN106. A new fission yeast 
hus (HU sensitive) mutant was screened in our lab that likely causes a checkpoint defect. This 
mutant is SN106. It was identified because it is partially sensitive to HU and UV but highly 
sensitive to MMS according to the preliminary results. It was thus predicted to have a mutation 
in a checkpoint gene since these mutants are usually sensitive to HU and MMS and the hus 
phenotype can be rescued by upregulation of Suc22, the small subunit of ribonucleotide 
reductase and the major regulation target of the DNA replication checkpoint. We therefore 
decided to investigate further on the SN106 mutant. 
We first examined the sensitivities of SN106 to DNA damage by UV, MMS and HU by using 
a standard spot assay. Rhp51 is involved in DNA strand break repair thus the rhp51 deletion 
strain showed a high sensitivity to UV, MMS and HU (Figure 4A). Rad3 controls both the 
DRC and DDC pathways (Yue, 2011) (Figure 1). The deletion strain of rad3 thus cannot grow 
on UV, MMS and HU plates (Figure 4A) due to elimination of its checkpoint functions. Chk1 
controls the DDC (Figure 1), thus the chk1 mutant showed a high sensitivity to MMS since 
MMS induces DNA damage in the G2 phase where the DDC is activated. Since Cds1 is 
involved in DRC not DDC, we observed a high killing effect of HU on cds1 deletion strain 
since HU induces replication stress in the S phase where DRC is activated. The SN106 mutant 
under similar conditions showed a higher sensitivity to MMS and not to HU similar to that 
observed in the chk1 deletion strain (Figure 4A). We thus assumed the mutant might be 
involved in DDC pathway since Chk1 is involved in the DDC.  
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We next examined the sensitivity of the SN106 mutant to DNA damage caused by BLM and 
CPT (Figure 4B). The rhp51 mutant was also sensitive to BLM and CPT. The rad3 mutant 
showed a high sensitivity to CPT and a partial sensitivity to BLM. The cds1 mutant showed 
a decreased sensitivity on CPT and BLM plates (Figure 4B) as it showed with HU in figure 
4A. Contrarily, the chk1 mutant showed higher sensitivity on CPT and BLM (Figure 4B) 
similar to what was observed with MMS indicating that most of the DNA damage that occurs 
at G2, the major cell cycle stage in S. pombe, is mainly dealt by the DDC mediated by Chk1. 
The SN106 mutant was also highly sensitive to MMS and BLM similar to the sensitivities in 
the chk1 mutant. This result again suggests that the SN106 mutation might be involved in the 
DDC. The SN106 mutant also showed a high sensitivity to BLM similar to the rhp51 deletion 
strain. Therefore, the mutation may not only affect the DDC but may also affect DNA repair 
















Figure 4: Drug sensitivity of the SN106 mutant. 
A. 10-fold dilutions of the cells were spotted on YE6S plates (Control) or YE6S plates containing 
UV, MMS or HU at the indicated concentrations. The wild type YJ374 cells and the deletion 
strains of rad3 (NR1827), cds1 (YJ60), rhp51 (Y167) and chk1 (NW222) were used as the 
controls. The plates were incubated at 30 °C for 3 days and then photographed.   
B. The strains used in A were spotted on YE6S plates (Control) or YE6S plates containing CPT 










SN106 mutant carries a single missense mutation in mus81. To identify the mutated gene, 
we transformed the SN106 mutant with S. pombe fork protection library (FPL) to screen 
colonies with conferred resistance to HU and MMS. The FPL consists of 17 genes that 
function in fork protection cloned in our lab. The vector used for our FPL carried ura4 marker 
so the transformed cells were grown on plates lacking uracil and then replicated onto plates 
containing HU and MMS. Plasmids were recovered from the yeast colonies with the conferred 
resistance to HU and MMS. These plasmids were digested with Hind III restriction enzymes 
followed by an agarose gel electrophoresis to study the pattern of the bands obtained. Plasmids 
obtained were compared with the typical bands in the FPL and the bands matched to 2 genes; 
mus81 and eme1 in the FPL (Figure 6A&B). The SN106 mutant was shown to be fully 
rescued by mus81 and partially by eme1 (Figure 7). Under similar spot assay condition in 
figure 4A&B, the SN106 mutant transformed with mus81 and eme1 showed resistance to HU, 
MMS and BLM (Figure 7A&B).  
 
Since mus81 was confirmed to be responsible for conferring MMS resistance in the SN106 
mutant, primers were designed for cloning the mus81 gene (Table 4). Genomic DNA of the 
SN106 mutant was extracted for PCR using the designed primers and amplified using the high 
fidelity Phusion DNA polymerase. The PCR product was analyzed by agarose gel 
electrophoresis and purified DNA sequencing. The DNA sequencing identified a single C-to-
T missense mutation that changed Arg412 to Cys amino acid in Mus81 (Figure 8). We hereafter 
renamed the SN106 mutant as mus81-1. We aligned S. pombe mus81 amino acid sequence to 
to the sequences of Mus81 homologs in other eukaryotic organisms. The result showed that 
the mutated Arg412 residue in the mus81-1 mutant is highly conserved in rats, mouse, humans, 









Figure 5: Drug sensitivity of the SN106 mutant transformed with FPL.  
 
This figure represents a replica of SN106 transformation with the FPL grown on YE6S 
media containing 5 mM HU or 0.03% MMS. Plasmids were recovered from the larger 
growing colonies on the MMS plate and digested with HindIII enzyme to identify the genes 
rescuing the mutant. The red dye seen on the plate is the lethality dye phloxin B. It helps 














Figure 6: Restriction analysis of plasmids using enzymes Hind III. 
A) The plasmids obtained from resistant colonies were digested with Hind III and run on 
agarose gel electrophoresis. Plasmids #1 to #4 likely contain mus81 because of the 
similar band patterns. Similarly, plasmid #6 likely carries eme1 gene. 
B) The FPL bands were also obtained by diagnostic digestion with Hind III. These bands 










Figure 7: Drug sensitivity of the SN106 mutant transformed with plasmids 
expressing wild type mus81 and eme1.  
HU and MMS sensitivity of the SN106 mutant transformed with mus81 and eme1 plasmids 
were assessed by spot assay and compared with wild type, rhp51, chk1, cds1 and rad3 








Figure 8: Identification of the single missense mutation in the SN106 mutant by 
DNA sequencing. 
DNA sequencing of mus81 cloned from SN106 revealed a single C-to-T mutation that 















Figure 9: Alignment of Mus81 with its homologous proteins in other organisms. 
The amino acid sequences of S. pombe Mus81 and its homologous proteins from mouse, 
rat, zebrafish, humans were aligned. The residue marked with asterisk is the mutated 





The mutation in mus81-1 abolishes the nuclease activity of Mus81 in humans. Our mus81-
1 mutation on R412 in S. pombe corresponds to R355 in human Mus81 (Figure 9). The 
nuclease domain in human Mus81 binds to the minor groove of DNA through alpha 3 helix 
(Gwon et al., 2014) (Figure 3) where the positively charged residues including R355 residue. 
In the work of Gwon et al., 2014, mutation that changed R355 to glutamate in alpha 3 helix 
almost completely eliminated the nuclease activities toward nicked Holliday junction and the 






Figure 10: Nuclease activities of various human Mus81-Eme1 mutants                          
A. Mus81 complex examined toward a nicked HJ. Various hMus81-Eme1 proteins (2 
nM) were incubated with a substrate DNA (20 nM) at 37°C for 2, 8, 20, and 60 minutes. 
Note, the mutant proteins containing the R355E mutation eliminated the incision activity.  
B. Nuclease activities of mutants examined toward a 3’ flap DNA as in A. The R355E 
mutation also elminated the nuclease activity. 
 
 
(Gwon et al., 2014) 
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The mus81-1 mutant has a moderate DRC defect. Since Mus81 physically binds to Cds1, 
the effector kinase for the DRC (Boddy et al., 2000) and genetically interacts with Crb2, the 
mediator for the DDC (Kanoh et al., 2003), we examined if the identified mutation disrupts 
the checkpoints by examining the phosphorylation levels of Mrc1, Cds1 and Chk1, the major 
checkpoint proteins in the DRC and DDC pathways.  
We first examined the Mrc1 phosphorylation since Mrc1 serves a mediator of the DRC in S. 
pombe (Figure1). The cells were treated with 15 mM HU for 3 hrs and phosphorylation 
levels were detected by Western blot with the phosphor-specific antibody as described in the 
Materials and Methods. Wild-type cell was used as the control and it showed a robust Mrc1 
phosphorylation after 3 h treatment with HU (Figure 11A). The rad3 deletion mutant 
showed an undetectable level of Mrc1 phosphorylation as expected (Figure 11A). The 
decreased protein level and phosphorylation of Mrc1 in the rad3 mutant is consistent with 
the lack of DRC because the activated DRC positively regulates the expression of Mrc1 
(Figure 1).  In mus81-1 mutant, we identified an increase protein level and the Mrc1 
phosphorylation but lower as compared to the level seen in WT cells, indicating a minor 
DRC defect (Figure 11A).  
We then examined Mrc1 phosphorylation in mus81-1 treated with 0.01% MMS for 90 mins. 
The WT cells showed some level of Mrc1 activation after the 90 mins (Figure 11B). The 
mus81-1 mutant however showed little to no Mrc1 phosphorylation level after the 90 mins. 
To confirm this result, we examined Mrc1 phosphorylation at 30 minutes intervals (Figure 
11C). In the WT, we observed a significant activation of the DRC with Mrc1 
phosphorylation at 60 mins (Figure 11C).  In mus81-1 mutant however we saw little to no 
Mrc1 phosphorylation until 120 mins indicating a significant delay in the DRC activation in 
the mutant compared to that in WT cells (Figure 11C).   
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We also examined phosphorylation of Cds1, the effector kinase for DRC, after treatment 
with 0.01% MMS for 90 min (Figure 12). For this purpose, we tagged Cds1 with HA tag 
and used anti-HA antibody agarose beads to pull down Cds1 from the cell lysates. Untagged 
strain was used as the control. WT cells showed robust Cds1 phosphorylation after the 
MMS treatment (Figure 12). As expected, rad3 mutant showed no phosphorylation of Cds1 
as its DRC has been eliminated. The phosphorylation of Cds1 in mus81-1 was significantly 



















      
 
 
Figure 11: Mrc1 phosphorylation in mus81-1 mutant treated with HU or MMS. 
A. Cells were treated with 15 mM HU for 3 hrs. Mrc1 phosphorylation was detected by Western 
blotting using phospho-specific antibody. Wild-type and rad3 cells were used as the control.                                                                                                                          
B. The cells used in A treated with 0.01% MMS for 90 minutes before the examination of Mrc1 
phosphorylation.                                                                                                                                    
C. Mrc1 phosphorylation was examined in cells were treated with 0.01% MMS for at 30 minute 



















Figure 12: Cds1 phosphorylation in mus81-1 mutant treated with MMS.  
 Cells were treated with 0.01% MMS for 90 minutes. Cds1 tagged with HA was 
immunoprecipitated with anti-HA antibody beads from the cell extracts. Untagged wild-





The mus81-1 mutant has a moderate DDC defect. To see whether mus81-1 affects the 
DDC, we examined the phosphorylation of Chk1, the effector kinase in the DDC pathway. 
We treated the cells with 0.01% MMS for 90 mins. We confirmed the HA tagged Chk1 by 
Western blotting and then examined the phosphorylation using IP as described in Materials 
and Methods. Untagged strain was used as a control. WT cells showed a significant increase 
in Chk1 phosphorylation (Figure 13A). The mus81-1 cells however showed a decreased 
Chk1 phosphorylation compared to that in WT cells (Figure 13A). To confirm this result, 
we examined Chk1 phosphorylation at 30 mins increasing time interval up to 120 minutes 
(Figure 13B). The mus81-1 mutant also showed decreased phosphorylation levels of Chk1 
compared to the WT cells. Quantitation results confirmed reduction of Chk1 
phosphorylation in mus81-1 (Figure 13B).  
With these results obtained, we surmised that the observed DRC defect could rather be due 
to a delay of the cell cycle at G2 in the presence of DNA damage. To ascertain these 
observations, we next monitored cell cycle progression by flow cytometer in the presence of 
0.01% for MMS for 120 mins (Figure 14). In the WT cells, we observed a decrease in the 
2C DNA content peak after 60 min indicating that the cell had repaired the MMS induced 
DNA damage and moved into the S phase (Figure 14). In contrast, the rad3 mutant ignored 
the damage and moved into the S phase because it has no checkpoint activation (Figure 14). 
The cells however got stuck in the S phase as seen in its 1C DNA content peak. Surprisingly 
we observed an increasing number of cells in the S phase in mus81-1. The cells ignored the 
MMS induced DNA damage at the G2 phase and continued to the S phase only after 30 





 To confirm the observed DDC defect, we monitored cell division by examination of cells 
under microscope to see whether there are any morphological defects. We stained the cells 
with Hoechst for genomic DNA and Blankophor for septum and examined cell septation 
during the course of 0.01% MMS treatment. In WT cells, cell division was delayed until 
after 60 min, suggesting checkpoint activation during the 60 min where the cell cycle was 
delayed to repair the DNA damage (Figure 15). Rad3 mutant however underwent cell 
division with “cut” cell phenotypes right from time 0 to 120 mins showing short cells 
(Figure 15). In contrast, mus81-1 mutant showed longer cells suggesting the cells remained 
in G2 for longer time due to delay in G2 because of the defect in DNA repair. This result 
suggests that although DDC is activated in mus81-1, a moderate DDC defect may allow the 






















Figure 13: Chk1 phosphorylation in the mus81-1 mutant.                                                                      
A. The cells were treated with 0.01% MMS for 90 minutes. Chk1 was tagged with HA 
epitope and pulled down from the cell lysates using anti-HA antibody beads and detected 
with anti-HA antibody. The cell extracts prepared were from an equal number of cells. 
Untagged cells, wild-type and rad3 cells were used as the controls.  
B. Chk1 phosphorylation was examined in cells were treated with 0.01% MMS at 30 minutes 
time intervals. 
 
B. Chk1 phosphorylation of mus81-1 with 0.01%MMS at different time. Phosphorylation 









Figure 14: FACS analysis of mus81-1 mutant in the presence of MMS.                                                                       
Cells were treated with 0.01% MMS for 120 minutes. During the course of the treatment, 
cell cycle progression was monitored by flow cytometry every 30 min.  















Figure 15:  Double staining analysis of mus81-1 treated with 0.01% MMS.                     
Cells stained with Hoechst for genomic DNA and Blankophor to examine cell 





Overexpression of Cds1 and Mrc1 in mus81-1 does not suppress drug sensitivity. Since 
we observed the DDC defect, we next examined if overexpression of some checkpoint genes 
could rescue or suppress the mutation upon treatment with the DNA damaging agents. We 
transformed the mus81-1 mutant with mrc1 and cds1 plasmids and performed drug sensitivity 
test (Figure 16). WT cells were used as control that was resistant to all the drugs I used 
whereas rad3 mutant showed sensitivity to all the drugs since its checkpoint has been 
eliminated. Overexpressing Mrc1 and Cds1 in mus81-1 did not significantly rescue the 








Figure 16: Overexpression of Cds1 and Mrc1 in mus81-1 mutant 
Mus81-1 mutant was transformed with plasmids expressing Cds1 or Mrc1. The 
transformed cells were assessed with drug sensitivity spot assay and compared with 
WT and rad3 deleted cells to examine if an increase in the protein levels of Cds1 and 
Mrc1 in mus81-1 mutant can partially or fully rescues the mutant from HU, MMS and 
UV.  
 
B. Chk1 phosphorylation of mus81-1 with 0.01%MMS at different time. 





            In this study, we characterized a potential checkpoint mutant SN106 in fission yeast 
that showed a dramatic sensitivity to DNA damage caused by MMS. The drug sensitivity test 
performed confirmed that the hypersensitivities of SN106 to MMS, CPT, BLM and not to HU 
(Figure 4A & 4B). Similar observations were made with chk1 mutant as it also showed a high 
sensitivity to MMS and not HU. We thus assumed the mutant might be involved in the DDC 
pathway since Chk1 is involved in the DDC pathway. The SN106 mutant also showed a high 
sensitivity to BLM similar to the observation made with the Rhp51 deletion strain. It is 
possible that the mutation may also affect DNA repair since Rhp51 is involved in strand break 
repair.  
          Next, we identified a single point mutation in mus81 that causes R412C amino acid 
substitution in the SN106 mutant and therefore renamed the mutant as mus81-1 (Figure 8). 
As previous studies have revealed the DNA repair activity of Mus81 through homologous 
recombination (HR), we predicted the identified mutation to be the cause of the sensitivity of 
the mutant to DNA damaging agents particularly to MMS. The dramatic cell killing effect 
observed in SN106 by MMS but not HU is due to the fact that MMS induces DNA damage 
at the G2 phase that requires repair through the HR pathway. A study confirms that cells 
deficient in recombination by Mus81 are hypersensitive to MMS and other agents that induce 
strand breaks (Lundin, 2005). Mus81 sequence alignment revealed that the mutated arginine 
residue is highly conserved from yeasts to humans (Figure 9). An earlier study showed that 
mutation of this residue in combination with other mutations in human Mus81 resulted in the 
significant loss of nuclease activities towards both Holliday junction and 3’ flap substrates 
(Figure 10). Therefore our mutated residue is likely to be involved in the nuclease activity of 
Mus81 in S. pombe. We also assumed that since arginine is a positively charged residue that 
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may provide bonding to a negatively charged phosphate group in DNA, the mutation to 
cysteine, could also cause destabilization of the protein/DNA structure thus decreasing the 
nuclease activity of the protein. This likely explains the cytotoxicity of the mus81-1 mutant 
to the DNA damaging agents.   
               We observed a severe DRC defect in mus81-1 (Figure 11A, 11B, 11C & 12). Further 
studies showed however that this observed DRC defect likely caused by the G2 cell cycle 
delay. Since the major cell cycle time in fission yeast is the G2 phase, most of the DNA 
damage would occur in the G2 phase of an asynchronized cell population. Once the DNA 
damage is repaired, the cell would then proceed to the S phase where the DRC can be 
activated. If DNA repair is delayed or fails to take place in the G2 phase, the cells will be held 
in this phase for a longer time until the repair is finished. With this understanding we attributed 
the DRC defect to the cycle delay in the G2 phase because of the defect in DNA repair. 
Monitoring the cell cycle progression by flow cytometry and microscopy confirmed this 
assumption. However, an increased number of cells in the S phase in the presence of MMS 
suggests although the DDC is activated in mus81-1, there might be a minor defect in the DDC.  
Chk1 phosphorylation analyses confirmed this minor DDC defect in mus81-1 (Figure 13). 
Because the mutation causes a defect in DNA repair, the MMS-treated mus81-1 mutant cells 











In this study, we identified a new mutation in the fission yeast mus81, a highly conserved 
gene in eukaryotes involved in DNA repair. The mutated amino acid residue is involved in 
the nuclease activity of Mus81 thus disrupted DNA repair and  sensitizes the fission yeast 
cells to HU, UV, CPT and particularly to MMS and BLM. The mutation also causes a 
moderate defect in the DDC pathway. The effect of this mutation on DNA repair and the DDC 
is meaningful as they crosstalk during the process of DNA repair. It is however still unclear 
if the mutation has a direct effect on the DRC although the cell cycle delay at G2 explains the 
observed DRC defect. Further characterization of this mutant may provide a better 
understanding of its checkpoint defects and its cell killing mechanisms with DNA damaging 
agents particularly to MMS and BLM. Further studies should also be done to identify 
suppressor genes of this mutation. The mus81-1 mutant may also be used as a study model in 
cancer biology as the Arginine to Cysteine change accounts for, or are commonly found in 
most cancers (Tsuber et al., 2017). This study showed that all single nucleotide mutations in 
about two thousand proteins in more than 18,000 cancer samples results from mutations that 
cause amino acid change from arginine to cysteine, histidine or tryptophan especially in the 
key tumor suppressor proteins (Tsuber et al., 2017) which explains that an increase in arginine 
substitutions in cancer is attributed to a high rate of mutation in four of the six codons and 
also the high rate of deamination in cytosine resulting in an increased C-to-T nucleotide 
substitutions. Lastly, the study on mus81-1 mutant may be informative to cancer 
chemotherapy as previous studies have reported that the downregulation of Mus81 sensitizes 
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